OTCMKTS:NSTM NovelStem International (NSTM) Stock Price, News & Analysis $0.01 0.00 (0.00%) As of 05/26/2026 02:33 PM Eastern Add Compare Share Share Stock Analysis Stock AnalysisChartEarningsSEC FilingsBuy This Stock About NovelStem International Stock (OTCMKTS:NSTM) View Price History Chart DataSkip Price History Chart 1 Day 5 Days 30 Days 90 Days 1 Year Advanced 1 Day 1 Day 5 Days 30 Days 90 Days 1 Year Advanced Show volume Show extended hours Get NSTM alerts:Sign Up Key Stats Today's Range$0.0124▼$0.013750-Day Range$0.0090▼$0.013752-Week Range$0.01▼$0.04Volume300 shsAverage Volume10,435 shsMarket Capitalization$675.82 thousandP/E Ratio0.23Dividend YieldN/APrice TargetN/AConsensus RatingN/A Company Overview NovelStem International Corp., a development stage biotechnology holding company, focuses on development and commercialization of stem cell-based diagnostic technology for cancer treatments and to reduce resistance to chemotherapy. The company was formerly known as Hollywood Media Corp. and changed its name to NovelStem International Corp. in September 2018. NovelStem International Corp. was incorporated in 1993 and is headquartered in Boca Raton, Florida. Read More Receive NSTM Stock News and Ratings via Email Sign-up to receive the latest news and ratings for NovelStem International and its competitors with MarketBeat's FREE daily newsletter. Submit View SMS TermsSMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. NSTM Stock News HeadlinesNovelStem International Corp.April 10, 2026 | barrons.comNSTM NovelStem International Corp.March 28, 2026 | seekingalpha.comThe REAL Reason Trump is Invading IranFor a moment… Forget about Trump’s ties to Israel. Forget about reports of Iran’s nuclear program. Because my research has led me to believe we’re risking World War 3 with Iran for a completely different reason.May 27 at 1:00 AM | Banyan Hill Publishing (Ad)NovelStem International Corp (NSTM) Real-TimeDecember 16, 2025 | nasdaq.comNovelStem International Delays Q1 2025 Report FilingMay 15, 2025 | tipranks.comArbitration Confirms NovelStem Joint Venture's Rights to Exploit 'Tom Clancy's Net Force' Franchise Globally via Film, TV, Online, Streaming, Gaming and MerchandisingJuly 13, 2023 | finance.yahoo.comGlencore InternationalApril 24, 2023 | forbes.comNovelStem, Focused on a Patented Genetic Platform Technology for Anti-Cancer Therapies, Reports 2022 Results on Form 10-KMarch 31, 2023 | finance.yahoo.comSee More Headlines NSTM Stock Analysis - Frequently Asked Questions How have NSTM shares performed this year? NovelStem International's stock was trading at $0.0090 at the start of the year. Since then, NSTM stock has increased by 52.2% and is now trading at $0.0137. How were NovelStem International's earnings last quarter? NovelStem International Corp. (OTCMKTS:NSTM) posted its quarterly earnings data on Wednesday, August, 6th. The company reported $0.06 earnings per share (EPS) for the quarter. How do I buy shares of NovelStem International? Shares of NSTM stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services. What other stocks do shareholders of NovelStem International own? Based on aggregate information from My MarketBeat watchlists, some other companies that NovelStem International investors own include Pure Gold Mining (PGM), Osisko Mining (OBNNF), New Gold (NGD), Pure Gold Mining (LRTNF), Hecla Mining (HL), Granada Gold Mine (GGM). Company Calendar Last Earnings8/06/2025Today5/27/2026Fiscal Year End12/31/2026Get Stock AlertsIndustry, Sector and Symbol Stock ExchangeOTCMKTS SectorMedical Industry MED - BIOMED/GENE Sub-IndustryRetail Current SymbolOTCMKTS:NSTM CIK912544 Webwww.novelstem.com Phone410-654-3315Fax561-998-2974Employees15Year FoundedN/AProfitability EPS (Trailing Twelve Months)$0.06 Trailing P/E Ratio0.23 Forward P/E RatioN/A P/E GrowthN/ANet Income$2.38 million Net MarginsN/A Pretax Margin76,760.66% Return on Equity-124.84% Return on Assets6,900.07% Debt Debt-to-Equity RatioN/A Current Ratio0.05 Quick Ratio0.05 Sales & Book Value Annual Sales$10 thousand Price / Sales67.58 Cash Flow$0.07 per share Price / Cash Flow0.21 Book Value($0.04) per share Price / Book-0.34Miscellaneous Outstanding Shares49,330,000Free Float42,603,000Market Cap$675.82 thousand OptionableNot Optionable Beta2.38 (Almost) Everything You Need To Know About The EV MarketLooking to profit from the electric vehicle mega-trend? Click the link to see our list of which EV stocks show the most long-term potential.Get This Free Report This page (OTCMKTS:NSTM) was last updated on 5/27/2026 by MarketBeat.com Staff. From Our PartnersThe 1934 playbookIn 1934, a legal government maneuver transferred billions in wealth overnight. Most Americans never saw it com...American Alternative | SponsoredSpaceX eyes a 1.75 trillion valuation - here's what to knowElon Musk's team has quietly filed confidential paperwork with the SEC for what Bloomberg estimates could be a...Brownstone Research | Sponsored$30 stock to buy before Starlink goes public (WATCH NOW!)In the next 3 minutes… James Altucher – legendary investor and venture capitalist… And someone who’s kno...Paradigm Press | SponsoredTrump's gold order: the announcement they won't put on the front pageOn August 15, 1971, Nixon interrupted prime-time television and ended the gold standard in 15 minutes - no deb...Reagan Gold Group | SponsoredYour book attachedBill Poulos is giving away his 'Safe Trade Options Formula' book for free - but only for a limited time throug...Profits Run | SponsoredMy feud with Zohran MamdaniEmmy-winning analyst releases his next big story Whitney Tilson shocked the nation on 60 Minutes when he ac...Stansberry Research | SponsoredRead now. Do not delete. You’ve been warned.Three Nobel Prize Winners expose this once-in-a-generation wealth shift: “Don’t Say I Didn’t Warn You” P...Porter & Company | SponsoredSpaceX IPO hides a much bigger storyThe SpaceX IPO could be the biggest in history at $1.75 trillion - but the real story isn't the IPO itself. ...Weiss Ratings | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding NovelStem International Corp. Please log in to your account or sign up in order to add this asset to your watchlist. Share NovelStem International With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In Email Me a Login Link or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free NSTM Stock Alerts